In patients with chronic renal failure on hemodialysis, plasma levels of the body's own DSIP were increased compared with healthy controls.
In plain wordsHigher levels of the body's own DSIP in blood were linked to chronic hemodialysis compared with healthy controls.
- Outcome
- IncreasePlasma DSIP in chronic hemodialysis patients
- Study
n = 32
- Comparator
- Healthy controls
- Outcome group
- Endogenous peptide levels · Kidney and urinary
Source sentences
The plasma concentrations of DSIP, beta-END, m-ENK, beta-LPH, and alpha-MSH were increased.
1 context sentence(design, population, supporting numbers)
were measured by radioimmunoassay in 22 stable patients with chronic renal failure on regular hemodialysis treatment and compared with those of 10 healthy controls.
This result measures the body's own Delta sleep-inducing peptide (DSIP). Nobody was given the peptide. It is not evidence about taking it.